ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2018

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data.

Anne J Kugler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.